Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tomoko Utsunomiya is active.

Publication


Featured researches published by Tomoko Utsunomiya.


Oncology Reports | 2012

Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells

Tetsuji Tanaka; Tao Bai; Saori Toujima; Tomoko Utsunomiya; Toshihide Matsuoka; Aya Kobayashi; Madoka Yamamoto; Noriyuki Sasaki; Yuko Tanizaki; Hirotoshi Utsunomiya; Junko Tanaka; Kazunori Yukawa

Using seven monoclonal SN38-resistant subclones established from ME180 human cervical squamous cell carcinoma cells, we examined the demethylation effects of 5-aza-2′-deoxycytidine (5-aza-CdR) on the SN38-sensitivity of the cells as well as the expression of death-associated protein kinase (DAPK) in the SN38-resistant cells. The DAPK expression levels were evaluated among parent ME180 cells, SN38-resistant ME180 cells and cisplatin-resistant ME180 cells by methylation-specific DAPK-PCR, quantitative RT-PCR and western blot analysis. The SN38-resistant cells co-treated with SN38 and 5-aza-CdR strongly exhibited enhanced SN38-sensitivities resembling those found in the parent cells. In the SN38-resistant subclones, no relationships were found between the restored SN38 sensitivity and hypermethylation of the DAPK promoter, DAPK mRNA expression, DAPK protein expression and induction of DAPK protein after 5-aza-CdR treatment, unlike the strong suppression of 5-aza-CdR-induced DAPK protein expression in the cisplatin-resistant subclones. These findings indicate that reversibly methylated molecules, but not DAPK, may regulate SN38 resistance, and that demethylating agents can be strong sensitizing anticancer chemotherapeutic drugs for SN38-resistant cancers.


Acta Histochemica Et Cytochemica | 2014

3,4-Dihydroxybenzaldehyde Derived from Prunus mume Seed Inhibits Oxidative Stress and Enhances Estradiol Secretion in Human Ovarian Granulosa Tumor Cells

Ryohei Kono; Sachiko Nomura; Yoshiharu Okuno; Misa Nakamura; Akihiro Maeno; Tomoko Kagiya; Akihiko Tokuda; Ken-ichi Inada; Akira Matsuno; Tomoko Utsunomiya; Hirotoshi Utsunomiya

Granulosa cells form ovarian follicles and play important roles in the growth and maturation of oocytes. The protection of granulosa cells from cellular injury caused by oxidative stress is an effective therapy for female infertility. We here investigated an effective bioactive compound derived from Prunus mume seed extract that protects granulosa cells from hydrogen peroxide (H2O2)-induced apoptosis. We detected the bioactive compound, 3,4-dihydroxybenzaldehyde (3,4-DHBA), via bioactivity-guided isolation and found that it inhibited the H2O2-induced apoptosis of granulosa cells. We also showed that 3,4-DHBA promoted estradiol secretion in granulosa cells and enhanced the mRNA expression levels of steroidogenic factor 1, a promoter of key steroidogenic enzymes. These results suggest that P. mume seed extract may have clinical potential for the prevention and treatment of female infertility.


Oncology Reports | 2012

Impaired death-associated protein kinase-mediated survival signals in 5-fluorouracil-resistant human endometrial adenocarcinoma cells

Tetsuji Tanaka; Tao Bai; Saori Toujima; Tomoko Utsunomiya; Hirotoshi Utsunomiya; Kazunori Yukawa; Junko Tanaka

A recent study showed that both 5-fluorouracil (5FU)-stimulated apoptosis and Fas-mediated apoptosis in human endometrial adenocarcinoma cells are enhanced by targeted knockdown of endogenous death-associated protein kinase (DAPK) with DAPK small-interfering RNAs. Therefore, we investigated the DAPK survival signals in three 5FU-resistant subclones. DAPK knockdown did not enhance 5FU-stimulated or Fas-mediated apoptosis in any of the three 5FU-resistant subclones, but the subclones acquired resistance to VP16-stimulated cell death that was DAPK-independent. Semi-quantitative flow cytometric analyses showed that there was no differential expression in nine cell surface antigens, including Fas, and six intracellular molecules, including DAPK, that may regulate cell death or survival between the parent cells and 5FU-resistant cells. DAPK mRNA and protein were expressed in the 5FU-resistant subclones at similar levels to the parent cells. These results indicate that acquisition of 5FU-resistance may be accompanied by impairment of common apoptotic signals regulating both DAPK-dependent and DAPK-independent pathways.


Molecular Medicine Reports | 2009

Direct effects of CPT-11 and SN38 on ovarian granulosa cells.

Tomoko Utsunomiya; Tetsuji Tanaka; Hirotoshi Utsunomiya; Naohiko Umesaki

This study aimed to clarify the mechanism by which apoptosis and Fas ligand (FasL) expression are induced in the ovarian granulosa cells of mice injected with irinotecan HCl (CPT-11). To this end, the direct effects of CPT-11 and its active metabolite, SN38, on granulosa cells were investigated. Normal ovarian tissue fragments obtained from 8-week-old female MCH mice were cultured in vitro with CPT-11 or SN38 and paraffin-embedded. After sectioning, the ovarian fragments were analyzed by TUNEL staining to detect apoptotic cells and by immunohistochemistry with an anti-FasL antibody to detect FasL expression. The results revealed no increase in TUNEL-positive granulosa cells in the ovarian tissue fragments cultured with CPT-11 or SN38. Furthermore, CPT-11 and SN38 did not induce FasL expression in the ovarian fragments. In conclusion, apoptosis and FasL expression induced in the ovarian granulosa cells of mice injected with CPT-11 is not caused by direct stimulation with CPT-11 or SN38. Therefore, systemic CPT-11 administration appears to induce apoptosis and FasL expression in granulosa cells via currently unknown endogenous FasL-inducing factors or by active metabolites of CPT-11 other than SN38.


International Journal of Oncology | 2008

A novel molecular mechanism for anticancer drug-induced ovarian failure: Irinotecan HCl, an anticancer topoisomerase I inhibitor, induces specific FasL expression in granulosa cells of large ovarian follicles to enhance follicular apoptosis

Tomoko Utsunomiya; Tetsuji Tanaka; Hirotoshi Utsunomiya; Naohiko Umesaki


International Journal of Molecular Medicine | 2003

Leptin inhibits decidualization and enhances cell viability of normal human endometrial stromal cells

Tetsuji Tanaka; Tomoko Utsunomiya; Tao Bai; Satoko Nakajima; Naohiko Umesaki


Oncology Reports | 2008

Irinotecan HCl, an anticancer topoisomerase I inhibitor, frequently induces ovarian failure in premenopausal and perimenopausal women

Tetsuji Tanaka; Tomoko Utsunomiya; Hirotoshi Utsunomiya; Naohiko Umesaki


Oncology Reports | 2008

Experimental characterization of recurrent ovarian immature teratoma cells after optimal surgery

Tetsuji Tanaka; Saori Toujima; Tomoko Utsunomiya; Kazunori Yukawa; Naohiko Umesaki


Oncology Reports | 2005

Reduced radiosensitivity and increased CD40 expression in cyclophosphamide-resistant subclones established from human cervical squamous cell carcinoma cells

Tetsuji Tanaka; Tao Bai; Kazunori Yukawa; Tomoko Utsunomiya; Naohiko Umesaki


Advances in obstetrics and gynecology | 2007

A retrospective study of clinical findings of pregnancy complicated with leiomyoma at Wakayama Medical University

Shigetaka Yagi; Sawako Minami; Eiji Boshi; Miwa Ikejima; Kazuharu Tanaka; Tomoko Utsunomiya; Katsuji Kokawa; Masaaki Iwahashi; Tetsuji Tanaka; Naohiko Umesaki

Collaboration


Dive into the Tomoko Utsunomiya's collaboration.

Top Co-Authors

Avatar

Tetsuji Tanaka

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar

Naohiko Umesaki

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tao Bai

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar

Saori Toujima

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Katsuji Kokawa

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar

Shigetaka Yagi

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar

Kazuharu Tanaka

Memorial Hospital of South Bend

View shared research outputs
Researchain Logo
Decentralizing Knowledge